Role for Proton Therapy in Locally Advanced Non–Small-Cell Lung Cancer?
This video reviews results of a randomized trial comparing intensity modulated radiation therapy vs passively scattered proton therapy for locally advanced non–small-cell lung cancer.
In this video, Zhongxing Liao, MD, of MD Anderson Cancer Center in Houston, Texas, reviews results of a randomized trial that compared intensity modulated radiation therapy (IMRT) vs passively scattered proton therapy in patients with locally advanced non–small-cell lung cancer.
Liao gave a presentation on this topic earlier this year at the 2017 Multidisciplinary Thoracic Cancers Symposium.
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
